Who are Europe's most active Health-tech investors?
One of the most common questions we hear from health-tech founders is, “who are the good seed-stage health-tech investors?” We compiled a U.S. list here, but lots of founders have asked us to put together a list for Europe. So here it is…
We opened this list to all investors in Europe, and we’re now sharing in time for the Q4 fundraising sprint. [If you’d like to submit your fund for future edits of this post, please do so here.]
The concentration of health specialists in Europe remains within pre-seed and seed, with a somewhat predictable bias to B2B software. Even with the entry of several later stage US funds to Europe in recent years, the list of series A+ investment funds focusing on health remains short. So feels a pertinent time to refresh memories of our O.V. cheque size (€5-€20m), and Series A-B focus in Europe.
About the author
Christina Farr
Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.
New York City